DK104116C - Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber. - Google Patents

Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber.

Info

Publication number
DK104116C
DK104116C DK115259AA DK115259A DK104116C DK 104116 C DK104116 C DK 104116C DK 115259A A DK115259A A DK 115259AA DK 115259 A DK115259 A DK 115259A DK 104116 C DK104116 C DK 104116C
Authority
DK
Denmark
Prior art keywords
preparation
therapeutically active
appetite suppressant
suppressant properties
properties
Prior art date
Application number
DK115259AA
Other languages
Danish (da)
English (en)
Original Assignee
Wallace & Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US726010A external-priority patent/US2990332A/en
Priority claimed from US753093A external-priority patent/US3084099A/en
Application filed by Wallace & Tiernan Inc filed Critical Wallace & Tiernan Inc
Application granted granted Critical
Publication of DK104116C publication Critical patent/DK104116C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/34—Introducing sulfur atoms or sulfur-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/01—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms
    • C07C205/03—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C205/04—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/08—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms
    • C07C205/09—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/14—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to acyclic carbon atoms
    • C07C205/16—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK115259AA 1958-04-02 1959-04-02 Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber. DK104116C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US726010A US2990332A (en) 1958-04-02 1958-04-02 Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US753093A US3084099A (en) 1958-08-04 1958-08-04 Therapeutic amine-resin complex composition and method of using same

Publications (1)

Publication Number Publication Date
DK104116C true DK104116C (da) 1966-04-04

Family

ID=27111252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115259AA DK104116C (da) 1958-04-02 1959-04-02 Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber.

Country Status (6)

Country Link
BE (1) BE577279A (it)
CH (1) CH391186A (it)
DK (1) DK104116C (it)
FR (1) FR465M (it)
GB (1) GB916789A (it)
NL (2) NL128079C (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467560A (en) * 1975-11-27 1977-03-16 Nicholas Int Ltd Preparation of ethylamine derivatives
EP0356035B1 (en) * 1988-08-12 1996-03-13 Astra Aktiebolag Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties

Also Published As

Publication number Publication date
NL237722A (it)
CH391186A (de) 1965-04-30
GB916789A (en) 1963-01-30
BE577279A (fr) 1959-10-01
NL128079C (it)
FR465M (it) 1961-05-02

Similar Documents

Publication Publication Date Title
DK104576C (da) Fremgangsmåde til fremstilling af sulfamylanthranilsyrer.
DK102793C (da) Fremgangsmåde til fremstilling af et 4-halogen-2-butynyl-N-(3-halogenphenyl)-carbamat.
DK112379B (da) Fremgangsmåde til fremstilling af 16α-alkyl-20-keto-pregnan-enolacylater.
DK109089C (da) Fremgangsmåde til fremstilling af 5-nitrofuraner.
DK104116C (da) Fremgangsmåde til fremstilling af et terapeutisk aktivt præparat med appetitnedsættende egenskaber.
DK115542B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme α-dithiosemicarbazoner.
DK96184C (da) Fremgangsmåde til fremstilling af symmetriske bis-aminer.
DK95832C (da) Fremgangsmåde til fremstilling af 1- eller 7-aminoalkylxantinderivater.
DK100818C (da) Fremgangsmåde til fremstilling af 6-sulfamyl-4-quinazoloner.
DK92116C (da) Fremgangsmåde til fremstilling af α-halogen-laktamer.
DK100110C (da) Fremgangsmåde til fremstilling af 2-cyan-3-oxo-steroider.
DK95680C (da) Fremgangsmåde til fremstilling af 3-cyanphentiazin.
DK92169C (da) Fremgangsmåde til fremstilling af ethyleniminoquinoner.
DK92118C (da) Fremgangsmåde til fremstilling af α-aminolaktamer.
DK89394C (da) Fremgangsmåde til fremstilling af dihydrodesoxystreptomycin.
DK99081C (da) Fremgangsmåde til fremstilling af 16α-alkyl-20-keto-steroider.
DK98688C (da) Fremgangsmåde til fremstilling af 6-desoxytetracycliner.
DK96180C (da) Fremgangsmåde til fremstilling af dialkylenimider.
DK95471C (da) Fremgangsmåde til fremstilling af sulfamylbenzamider.
DK95470C (da) Fremgangsmåde til fremstilling af sulfamylbenzamider.
DK95469C (da) Fremgangsmåde til fremstilling af sulfamylbenzamider.
DK93398C (da) Fremgangsmåde til fremstilling af ethynylcarbinoler.
DK92117C (da) Fremgangsmåde til fremstilling af 3-nitro-azacyklo-heptanon-2-N-karboklorid.
DK91568C (da) Fremgangsmåde til fremstilling af 1-karbamylazetidiner.
DK91971C (da) Fremgangsmåde til fremstilling af threo-β-p-nitrophenylserin.